Financial reports
20-F
2023 FY
Annual report (foreign)
25 Apr 24
20-F/A
2022 FY
Annual report (foreign) (amended)
22 Sep 23
20-F
2022 FY
Annual report (foreign)
21 Apr 23
20-F
2021 FY
Annual report (foreign)
16 May 22
NT 20-F
Notice of late annual filing (foreign)
29 Apr 22
20-F
2020 FY
Annual report (foreign)
30 Apr 21
20-F
2019 FY
Annual report (foreign)
30 Apr 20
Current reports
6-K
Current report (foreign)
16 Aug 24
6-K
Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading
10 Jul 24
6-K
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
20 May 24
6-K
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing
25 Apr 24
6-K
Current report (foreign)
8 Mar 24
6-K
Aesthetic Medical International Announces Change of Auditor and Change of Director
12 Dec 23
6-K
Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
8 Sep 23
6-K
Aesthetic Medical International Reports First Half of 2023 Unaudited Financial Results
5 Sep 23
6-K
Current report (foreign)
17 Aug 23
6-K
Aesthetic Medical International Reports First Quarter 2023 Unaudited Financial Results
17 May 23
Registration and prospectus
25-NSE
Exchange delisting
19 Jul 24
RW
Registration withdrawal request
23 May 23
F-3
Shelf registration (foreign)
17 Jun 22
S-8
Registration of securities for employees
24 Apr 20
424B4
Prospectus supplement with pricing info
25 Oct 19
F-1/A
Registration statement (foreign) (amended)
23 Oct 19
8-A12B
Registration of securities on exchange
15 Oct 19
F-1/A
Registration statement (foreign) (amended)
15 Oct 19
F-6
Registration for ADRs (foreign)
15 Oct 19
F-1
Registration statement (foreign)
30 Sep 19
Proxies
No filings
Other
UPLOAD
Letter from SEC
16 Oct 23
CORRESP
Correspondence with SEC
5 Sep 23
UPLOAD
Letter from SEC
22 Aug 23
CORRESP
Correspondence with SEC
3 Aug 23
UPLOAD
Letter from SEC
21 Jul 23
EFFECT
Notice of effectiveness
25 Oct 19
EFFECT
Notice of effectiveness
25 Oct 19
CERT
Certification of approval for exchange listing
24 Oct 19
CORRESP
Correspondence with SEC
21 Oct 19
CORRESP
Correspondence with SEC
21 Oct 19
Ownership
SC 13D/A
Peak Asia Investment Holdings V Ltd
17 Aug 23
SC 13D/A
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
17 Aug 23
SC 13D/A
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
24 Feb 23
SC 13D/A
Peak Asia Investment Holdings V Ltd
29 Jul 22
SC 13D
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
29 Jul 22
SC 13D
Zhou Pengwu
29 Jul 22
SC 13D
Ding Wenting
29 Jul 22
SC 13D/A
Hainan Runming Biotechnology Co., Ltd.
14 Jul 22
SC 13D
Hainan Runming Biotechnology Co., Ltd.
10 Jun 22
SC 13G/A
IDG-Accel China Growth Fund III L.P.
28 Feb 22